NCT00646230 2026-04-14
IV Fenretinide
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
Clinical Trials
7 trialsNCT02163356 2022-03-31
SPOC2013-001
South Plains Oncology Consortium
Phase 1 Terminated
NCT02075177 2022-03-21
Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma
South Plains Oncology Consortium
No longer available
NCT00006080 2018-06-27
Fenretinide in Treating Patients With Recurrent Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00053326 2013-10-08
Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003191 2013-02-07
Fenretinide in Treating Children With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00075491 2013-01-24
Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 2 Terminated